MedTrace Logo

Platelet Transfusion in Acute Intracerebral Hemorrhage

NCT00699621 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2010-07-02

No results posted yet for this study

Summary

* To prove whether use of antiplatelet agents results into a rapid enlargement of hematoma after onset of acute intracerebral hemorrhage.
* To prove the efficacy and safety of platelet transfusion for prevention of hematoma growth in patients who were stricken by acute intracerebral hemorrhage while being on antiplatelet medication.

Conditions

  • Intracerebral Hemorrhage

Interventions

BIOLOGICAL

platelets

Four units of fresh platelets will be infused immediately

Sponsors & Collaborators

  • University of Helsinki

    collaborator OTHER

  • University of Oulu

    lead OTHER

Principal Investigators

  • Matti E Hillbom, MD, PhD · Oulu University Central Hospital, Department of Neurology

  • Seppo S Juvela, MD, PhD · Turku University Central Hospital, Department of Neurosurgery

  • Lauri Soinne, MD, PhD · Helsinki University Central Hospital, Department of Neurology

  • Olli Häppölä, MD, PhD · Helsinki University Central Hospital

  • Aimo Rissanen, MD, PhD · Keski-Suomen Keskussairaala

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2014-07-31
Completion
2014-12-31

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00699621 on ClinicalTrials.gov